Primary Device ID | 10190302000048 |
NIH Device Record Key | 5de54715-7166-484c-ba8d-96803020d5e3 |
Commercial Distribution Discontinuation | 2022-06-01 |
Commercial Distribution Status | Not in Commercial Distribution |
Brand Name | SPOT-Light® Tissue Pretreatment Kit |
Version Model Number | 008401 |
Company DUNS | 080131636 |
Company Name | LIFE TECHNOLOGIES CORPORATION |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | true |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 10190302000048 [Primary] |
NJT | IMMUNOHISTOCHEMISTRY REAGENTS AND KITS |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 4 |
Public Version Date | 2022-06-07 |
Device Publish Date | 2016-08-01 |
10190302018982 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Assay | 2025-02-25 Component 1 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302018999 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Positive Control | 2025-02-25 Component 2 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019002 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Negative Control | 2025-02-25 Component 3 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019019 - TaqPath™ 1-Step Select Master Mix (No ROX) | 2025-02-25 Component 4 of 4 of A56123 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019026 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Assay | 2025-02-25 Component 1 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019033 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Positive Control | 2025-02-25 Component 2 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019040 - TaqPath™ COVID-19, Flu A, Flu B, RSV Select Negative Control | 2025-02-25 Component 3 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
10190302019057 - TaqPath™ 1-Step Select Master Mix (No ROX) | 2025-02-25 Component 4 of 4 of A56124 (Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() SPOT-LIGHT 77378903 3553087 Dead/Cancelled |
Invitrogen Corporation 2008-01-23 |
![]() SPOT-LIGHT 76154297 2531768 Live/Registered |
INVITROGEN CORPORATION 2000-10-26 |